Molecular cloning has identified three distinct proteins responsible for plasma membrane monoamine transport. Although functional analysis indicates that each can recognize multiple monoamines as substrates, selective expression within dopamine, norepinephrine, and serotonin cell populations of the brain suggests that each probably transports a single substrate in vivo . In contrast, molecular cloning has identified two vesicular monoamine transporters (VMATs), one expressed in the adrenal medulla and other neuroendocrine tissues (VMAT1) and the other in the brain (VMAT2). Although VMATs have no sequence similarity to the plasma membrane transporters or receptors for monoamines, they do contain individual residues implicated in substrate recognition by these other proteins. In addition to those residues required for substrate recognition, the comparison of VMAT1 and VMAT2 indicates that other residues may modulate the recognition of ligand. VMAT2 has an apparent affinity for most substrates approximately threefold higher than VMAT1. In addition, only VMAT2 recognizes histamine, and tetrabenazine inhibits only VMAT2. Residues have been identified that have a variety of roles in substrate recognition by VMATs. Analogous to other membrane proteins that interact with monoamines, VMATs contain an aspartate in TMD1 and serines in TMD3 that are required for transport activity.
Read full abstract